| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 6019- | CGA, | immuno, | Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects |
| - | in-vivo, | Melanoma, | NA |
| 6037- | CGA, | Pharmacokinetics and brain penetration study of chlorogenic acid in rats |
| - | in-vivo, | AD, | NA | - | in-vivo, | Stroke, | NA |
| 6040- | CGA, | Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway |
| - | in-vivo, | AD, | NA |
| 6041- | CGA, | Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study |
| - | Trial, | AD, | NA |
| 6043- | CGA, | SeNPs, | Enhanced Effect of Combining Chlorogenic Acid on Selenium Nanoparticles in Inhibiting Amyloid β Aggregation and Reactive Oxygen Species Formation In Vitro |
| - | in-vitro, | AD, | NA |
| 6035- | CGA, | Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial |
| - | Trial, | Nor, | NA |
| 6029- | CGA, | Pharmacokinetics of chlorogenic acids absorbed in human plasma and their metabolites following oral ingestion of coffee drink |
| - | Trial, | Nor, | NA |
| 6028- | CGA, | Chlorogenic acids from green coffee extract are highly bioavailable in humans |
| - | Trial, | Nor, | NA |
| 7185- | CHA, | Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism |
| - | vitro+vivo, | GBM, | A172 | - | in-vitro, | GBM, | T98G | - | in-vitro, | GBM, | U87MG |
| 7163- | CHA, | The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | OS, | U2OS | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HeLa | - | in-vivo, | Ovarian, | SKOV3 |
| 7161- | CHA, | Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases |
| - | Review, | Var, | NA |
| 6001- | Chit, | Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: Promises and outlooks |
| - | Review, | Var, | HepG2 | - | Review, | AD, | NA |
| 6071- | CHL, | First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent |
| - | Trial, | Nor, | NA |
| 6083- | CHOC, | Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer |
| - | Review, | Colon, | NA |
| 6087- | CHOC, | Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial |
| - | Trial, | Nor, | NA |
| - | Trial, | Nor, | NA |
| 6090- | CHOC, | Cocoa Flavanol Intake and Biomarkers for Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| - | Review, | Nor, | NA |
| 6107- | Chol, | Choline supplements: An update |
| - | Review, | AD, | NA |
| 6111- | Chol, | The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease |
| - | Human, | AD, | NA |
| 6113- | Chol, | Association between choline supplementation and Alzheimer’s disease risk: a systematic review protocol |
| - | Review, | AD, | NA |
| 6108- | Chol, | Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6114- | Chol, | Dietary Choline Intake and Risk of Alzheimer's Dementia in Older Adults |
| - | Study, | AD, | NA |
| 6115- | Chol, | Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study |
| - | Study, | AD, | NA |
| 6117- | Chol, | Citicoline, | Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| - | Trial, | AD, | NA |
| 6120- | Chol, | Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease |
| - | Trial, | AD, | NA |
| 6101- | Chol, | Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men |
| - | Human, | Nor, | NA |
| 6098- | Chol, | Choline |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 3701- | Chol, | Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation |
| - | in-vivo, | AD, | NA |
| 6134- | CHr, | QC, | RT, | Comparative Pharmacokinetics and Safety of a Micellar Chrysin–Quercetin–Rutin Formulation: A Randomized Crossover Trial |
| - | Trial, | Nor, | NA |
| 6122- | CHr, | Disposition and metabolism of the flavonoid chrysin in normal volunteers |
| - | Human, | Nor, | NA |
| 2806- | CHr, | Se, | Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy |
| - | in-vitro, | Var, | NA |
| 2784- | CHr, | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
| - | Review, | Var, | NA |
| 7406- | Chy, | Antiamnesic activity of an ayurvedic formulation chyawanprash in mice |
| - | in-vivo, | AD, | NA |
| 7432- | Chy, | A Cytogenetic Study on the Efficacy of Chyawanprash Awaleha as an Antioxidant in Oral Premalignant Cancer |
| - | Trial, | Oral, | NA |
| 7433- | Chy, | Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study |
| - | Trial, | Nor, | NA |
| 7435- | Chy, | Golden Ager Chyawanprash with Meager Evidential Base from Human Clinical Trials |
| - | Review, | Nor, | NA |
| 6627- | Cic, | Determination of Cichoric Acid as a Biomarker in Echinacea Purpurea Cultivated in Iran Using High Performance Liquid Chromatography |
| - | Study, | Nor, | NA |
| 6629- | Cic, | Chicoric Acid: Natural Occurrence, Chemical Synthesis, Biosynthesis, and Their Bioactive Effects |
| - | Review, | Nor, | NA |
| 9116- | Cim, | Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells |
| - | Trial, | CRC, | NA |
| 6140- | Cin, | HCAs, | Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review) |
| - | Review, | Var, | NA |
| 8995- | Citicoline, | Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport |
| - | in-vivo, | Stroke, | NA |
| 8996- | Citicoline, | Effect of citicoline on cognitive function and functional recovery in patients with mild-to-moderate traumatic brain injury: a randomized placebo-controlled trial |
| - | Trial, | Nor, | NA |
| 8998- | Citicoline, | Rad, | The impact of citicoline on brain mitochondrial dysfunction induced in rats after head irradiation |
| - | in-vivo, | Nor, | NA |
| 8991- | Citicoline, | Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study |
| - | Human, | Nor, | NA |
| 8990- | Citicoline, | Effect of oral CDP-choline on plasma choline and uridine levels in humans |
| - | Trial, | Nor, | NA |
| - | Trial, | AD, | NA |
| 1583- | Citrate, | Extracellular citrate and metabolic adaptations of cancer cells |
| - | Review, | Var, | NA |
| 1586- | Citrate, | Extracellular Citrate Is a Trojan Horse for Cancer Cells |
| - | in-vitro, | Liver, | HepG2 |
| 1582- | Citrate, | Clinical report: A patient with primary peritoneal mesothelioma that has improved after taking citric acid orally |
| - | Case Report, | PerC, | NA |
| 1581- | Citrate, | Hypothesis proved. . .citric acid (citrate) does improve cancer:A case of a patient suffering from medullary thyroid cancer |
| - | Case Report, | Thyroid, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid